Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,531
Closed -$2.78M 73
2023
Q2
$2.78M Sell
12,531
-146
-1% -$33.9K 1.38% 35
2023
Q1
$3.06M Sell
12,677
-30
-0.2% -$7.36K 1.6% 26
2022
Q4
$3.34M Buy
12,707
+5
+0% +$1.34K 1.84% 21
2022
Q3
$2.86M Sell
12,702
-68
-0.5% -$16.5K 1.8% 20
2022
Q2
$3.11M Sell
12,770
-89
-0.7% -$21.8K 1.92% 20
2022
Q1
$3.11M Buy
12,859
+543
+4% +$125K 1.84% 26
2021
Q4
$2.77M Buy
12,316
+456
+4% +$96.2K 1.45% 36
2021
Q3
$2.52M Sell
11,860
-150
-1% -$34.5K 1.63% 34
2021
Q2
$2.93M Buy
12,010
+3
+0% +$738 1.71% 29
2021
Q1
$2.99M Buy
12,007
+518
+5% +$124K 1.84% 25
2020
Q4
$2.64M Sell
11,489
-166
-1% -$38.3K 1.75% 28
2020
Q3
$2.96M Sell
11,655
-330
-3% -$81.8K 2.19% 14
2020
Q2
$2.83M Sell
11,985
-174
-1% -$39.7K 2.35% 12
2020
Q1
$2.46M Sell
12,159
-82
-0.7% -$17.9K 2.54% 10
2019
Q4
$2.95M Buy
+12,241
New +$2.7M 2.2% 18

Other funds holding AMGN

Watchman Group's AMGN Position: Q3 2023 in Review

Watchman Group sold out of Amgen (AMGN) in Q3 2023, closing a stake of 12,531 shares — an estimated $2.78M sold.

Watchman Group first reported a position in AMGN in Q4 2019 and held it in 15 quarters. The position peaked at $3.34M in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Watchman Group reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Watchman Group sold 12,531 Amgen shares in Q3 2023, an estimated $2.78M.
  • Watchman Group first reported a position in Amgen in Q4 2019 and held it in 15 quarters.
  • Watchman Group's Amgen position peaked at $3.34M in Q4 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Watchman Group's 13F filing for Q3 2023, filed 9 Nov 2023.